These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24277075)

  • 1. CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation.
    Torossian F; Anginot A; Chabanon A; Clay D; Guerton B; Desterke C; Boutin L; Marullo S; Scott MG; Lataillade JJ; Le Bousse-Kerdilès MC
    Blood; 2014 Jan; 123(2):191-202. PubMed ID: 24277075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging ligand-dependent activation of CXCR7.
    Luker KE; Gupta M; Steele JM; Foerster BR; Luker GD
    Neoplasia; 2009 Oct; 11(10):1022-35. PubMed ID: 19794961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.
    Coggins NL; Trakimas D; Chang SL; Ehrlich A; Ray P; Luker KE; Linderman JJ; Luker GD
    PLoS One; 2014; 9(6):e98328. PubMed ID: 24896823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
    Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
    Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
    Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
    J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR7 participates in CXCL12-mediated migration and homing of leukemic and normal hematopoietic cells.
    Melo RCC; Ferro KPV; Duarte ADSS; Olalla Saad ST
    Stem Cell Res Ther; 2018 Feb; 9(1):34. PubMed ID: 29433559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
    Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
    Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
    Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
    Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
    Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
    Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7.
    Ehrlich A; Ray P; Luker KE; Lolis EJ; Luker GD
    Biochem Pharmacol; 2013 Nov; 86(9):1263-71. PubMed ID: 23973527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMD3100 is a CXCR7 ligand with allosteric agonist properties.
    Kalatskaya I; Berchiche YA; Gravel S; Limberg BJ; Rosenbaum JS; Heveker N
    Mol Pharmacol; 2009 May; 75(5):1240-7. PubMed ID: 19255243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells.
    Basu S; Broxmeyer HE
    J Immunol; 2009 Dec; 183(11):7478-88. PubMed ID: 19917679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.
    Hartmann TN; Grabovsky V; Pasvolsky R; Shulman Z; Buss EC; Spiegel A; Nagler A; Lapidot T; Thelen M; Alon R
    J Leukoc Biol; 2008 Oct; 84(4):1130-40. PubMed ID: 18653785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
    Zieger-Naumann K; Kuhl F; Engele J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR7 mediates SDF1-induced melanocyte migration.
    Lee E; Han J; Kim K; Choi H; Cho EG; Lee TR
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):58-66. PubMed ID: 22978759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
    Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
    J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxy-terminus of CXCR7 regulates receptor localization and function.
    Ray P; Mihalko LA; Coggins NL; Moudgil P; Ehrlich A; Luker KE; Luker GD
    Int J Biochem Cell Biol; 2012 Apr; 44(4):669-78. PubMed ID: 22300987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
    Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
    Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
    Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
    Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.